FINWIRES · TerminalLIVE
FINWIRES

S&P Upgrades LG Electronics to BBB+ on Segment Growth

By

S&P Global Ratings has upgraded LG Electronics' (KRX:066570) long-term issuer and issue credit ratings to BBB+ from BBB, according to a recent release.

The group will lessen its debt and boost its financial base through the growth in home appliances and solid gains from subsidiary LG Display, S&P said.

The company will see better profitability over the next one to two years as LG Display transitions toward high-end OLED panels, the rating agency said.

The company has a robust lineup among premium products in its home appliance solution division, diversified services within its subscription segment, and rising penetration in its higher-margin business to business (B2B) division, S&P said.

LG Display will also further develop through an enhanced product mix, according to S&P.

The outlook is stable, stemming from S&P's belief that the company's core business competitiveness will anchor credit strength, yield solid free cash flow, and lessen debt.

Notable shifts in the company's debt-to-EBITDA ratio driven by its TV or home appliances businesses or market position across core segments could lead to future rating actions.

Related Articles

Asia

Hong Kong Court Orders Stay in Case Against Wai Chun, Wai Chun Bio-Technology

Wai Chun (HKG:1013) said the Hong Kong High Court ordered a stay on the proceedings of a lawsuit requiring the firm and unit Wai Chun Bio-Techn ology (HKG:0660) to pay HK$2.7 million plus interest and costs each to Island Sky.An appeal to present new findings was also dismissed, while future hearings have been cancelled, according to a Wednesday Hong Kong bourse filing.The ruling came after the parties reached an agreement in May, with Wai Chun and Wai Chun Bio-Technology agreeing to pay HK$4.2 million to settle the lawsuit.

$HKG:0660$HKG:1013
Asia

Haohai Subsidiary Gets China Nod for In-Eye Lenses for Cataract Patients

China's drug administrator approved Shanghai Haohai Biological Technology (SHA:688366) subsidiary Henan Saimei Vision Biotechnology's trifocal intraocular lens.The product is indicated for vision correction in adult cataract patients and helps improve, near, intermediate, and far vision, according to a Wednesday filing with the Shanghai bourse.

$SHA:688366
Asia

S&P Rates Bank of China (Macau)'s Proposed Renminbi Notes A

S&P Global Ratings has given Bank of China (Macau)'s (HKG:3988, SHA:601988) proposed renminbi-denominated notes an A long-term issue rating, according to a recent release.The Bank of China subsidiary will draw down the notes from the parent's $40 billion medium-term note program.The notes will serve as the issuer's direct, general, unsubordinated, unconditional, and unsecured obligations, S&P said.They will also at all times rank equally with the bank's other senior and unsecured obligations, except those preferred by law, the rating agency said.The notes' rating is equivalent to the parent's long-term issuer credit rating, given that the bank's creditworthiness is equal to that of the subsidiary, S&P said.

$HKG:3988$SHA:601988